Anlon Healthcare quarterly results

Q2 FY27 · Jul–Sep 2026

₹ crore	Q2 FY27	Year before	Change
Revenue	106	—	—
EBITDA	25.2	—	—
EBITDA margin	23.9%	—	—
Profit before tax	23.5	—	—
Net profit	17.2	—	—
EPS	₹0.32	—	—

Every quarter

₹ crore except per share

Tap a line for its trend	Q2 FY27Sep 2026	Q1 FY27Jun 2026	Q4 FY26Mar 2026

Expenses
	106	87.6	50.9
	0.0	0.1	0.0
	106	87.6	50.9
	48.7	73.0	52.8
	24.2	−7.0	−24.9
	2.6	1.9	1.5
	0.9	0.9	0.6
	1.0	1.1	0.3
	4.9	3.9	6.2
	82.2	74.0	36.5
	25.2	15.6	15.3
	24.3	14.5	15.0
Profit
	23.5	13.7	14.4
	23.5	13.7	14.4
	5.9	3.5	1.9
	0.4	1.9	1.5
	6.3	5.4	3.4
	17.2	8.3	11.1
	17.2	8.3	11.1
	0.0	−0.0	−0.1
	17.2	8.3	11.0
	13.4	—	10.5
	3.8	0.0	0.6
Per share
	₹0.32	₹0.16	₹2.33
	₹0.32	₹0.16	₹2.33
Other comprehensive income — detail
	0.0	−0.0	−0.1
	0.0	−0.0	—
	0.0	−0.0	0.1
	—	0.0	−0.0
	13.4	—	10.4
	3.8	—	0.6
Per share — as-filed variants
	₹0.32	₹0.16	₹2.33
	₹0.32	₹0.16	₹2.33
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	32.7	21.5	23.0
	31.0%	24.5%	45.3%
Adjusted (ex-exceptional items) — derived
	23.5	13.7	14.4
	17.2	8.3	11.1
	₹0.32	₹0.16	₹2.33

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

AHCL₹24.47

Anlon Healthcare Limited

· Pharma & Health

Annual Quarterly₹ CrorePeersANUHPHR WANBURY BAJAJHCARE ZIMLAB THEMISMED LINCOLN SIGACHI VALIANTLABMcap ₹130 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Revenue from Operations	50.9	87.6	105.6
Other Income	0.0	0.1	0.0
Total Income	50.9	87.6	105.7
Expenses
+ Cost of Materials Consumed	52.8	73.0	48.7
+ Changes in Inventories	-24.9	-7.0	24.2
+ Employee Benefit Expense	1.5	1.9	2.6
+ Finance Costs	0.6	0.9	0.9
+ Depreciation & Amortisation	0.3	1.1	1.0
+ Other Expenses	6.2	3.9	4.9
Total Expenses	36.5	74.0	82.2
EBITDA	15.3	15.6	25.2
EBIT	15.0	14.5	24.3
Profit
PBT before Exceptional Items	14.4	13.7	23.5
Pretax Income	14.4	13.7	23.5
+ Current Tax	1.9	3.5	5.9
+ Deferred Tax	1.5	1.9	0.4
Tax Expense	3.4	5.4	6.3
Net Income	11.1	8.3	17.2
+ Net Income — Continuing Ops	11.1	8.3	17.2
+ Other Comprehensive Income	-0.1	-0.0	0.0
Total Comprehensive Income	11.0	8.3	17.2
Net Income to Common	10.5	—	13.4
Minority Interest	0.6	0.0	3.8
Per Share
Basic EPS	2.33	0.16	0.32
Diluted EPS	2.33	0.16	0.32
Other Comprehensive Income — detail
+ Other Comprehensive Income	-0.1	-0.0	0.0
+ Items NOT to be Reclassified to P&L	—	-0.0	0.0
+ Tax on Items NOT to be Reclassified	0.1	-0.0	0.0
+ Tax on Items to be Reclassified	-0.0	0.0	—
Comprehensive Income — Owners of Parent	10.4	—	13.4
Comprehensive Income — Non-controlling Interests	0.6	—	3.8
Per Share — as-filed variants
Basic EPS — Continuing Operations	2.33	0.16	0.32
Diluted EPS — Continuing Operations	2.33	0.16	0.32
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	23.0	21.5	32.7
Gross Margin %	45.28	24.53	31.00
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	14.4	13.7	23.5
Net Income Adj (tax-effected)	11.1	8.3	17.2
EPS Adj	2.33	0.16	0.32
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	2.00	2.00
Paid Up Equity Capital	53.2	106.3	106.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q2 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Anlon Healthcare Q2 FY27 results (July–September 2026)

Filed with NSE on Thursday, 29 October 2026 at 5:32 pm IST

Anlon Healthcare (NSE: AHCL) reported its Q2 FY27 results (July–September 2026) on Thursday, 29 October 2026 at 5:32 pm IST. Consolidated net profit attributable to shareholders was ₹13.4 crore, up 61.4% from ₹8.3 crore in Q1 FY27. Revenue from operations was ₹106 crore, up 20.6% from the previous quarter.

Q2 FY26 results (a year earlier): 11 November 2025
Q3 FY27 results due by: 14 February 2027

Q2 FY27 at a glance · consolidated

Net profit (shareholders'): ₹13.4 Cr+61.4% vs Q1 FY27Total incl. minority interest ₹17.2 Cr
Revenue from operations: ₹106 Cr+20.6% vs Q1 FY27
Operating margin (EBIT): 23.0%+6.4 pts vs Q1 FY27EBIT ₹24.3 Cr
EBITDA: ₹25.2 Cr+61.9% vs Q1 FY27margin 23.9%
Earnings per share (basic): ₹0.32+100.0% vs Q1 FY27
Net profit margin: 12.7%+3.2 pts vs Q1 FY27

Questions

What was Anlon Healthcare's net profit in Q2 FY27?

Consolidated net profit attributable to shareholders was ₹13.4 crore, up 61.4% from ₹8.3 crore in Q1 FY27. Including the minority shareholders' share, total profit was ₹17.2 crore.

What was Anlon Healthcare's operating margin in Q2 FY27?

Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹24.3 crore, a margin of 23.0%, against 16.6% in Q1 FY27. EBITDA was ₹25.2 crore, 23.9% of revenue.

What is Anlon Healthcare's net profit margin?

Anlon Healthcare's net profit margin was 12.7% in Q2 FY27 (net profit attributable to shareholders as a share of revenue from operations). For FY26 as a whole it was 16.6%.

What was Anlon Healthcare's revenue in Q2 FY27?

Revenue from operations was ₹106 crore, up 20.6% from the previous quarter.

What was Anlon Healthcare's net profit in FY26?

Consolidated net profit attributable to shareholders was ₹28.5 crore in FY26 (April 2025–March 2026).

What was Anlon Healthcare's revenue in FY26?

Revenue from operations was ₹172 crore in FY26 (April 2025–March 2026).

What was Anlon Healthcare's EPS in Q2 FY27?

Basic earnings per share were ₹0.32.

When did Anlon Healthcare announce its Q2 FY27 results?

On Thursday, 29 October 2026 at 5:32 pm IST, in its results filing to the stock exchanges. A year earlier it reported Q2 FY26 on 11 November 2025.

When will Anlon Healthcare announce its Q3 FY27 results?

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

Where do these Anlon Healthcare figures come from?

From Anlon Healthcare's own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 29 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.